Los inhibidores de la indoisoquinolina topoisomerasa se unen fuertemente y estabilizan el promotor G-cuadruplex y regulan a la baja el MYC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.Las indenoisoquinolinas, una nueva clase de fármacos contra el cáncer, suprimen efectivamente la expresión del oncogén MYC al dirigirse al cuádruple MycG4. Esta doble acción, que inhibe tanto el MYC como la topoisomerasa I, ofrece una estrategia prometedora para el tratamiento del cáncer.
Área De La Ciencia
- En el campo de la oncología
- Biología molecular
- Descubrimiento de drogas
Sus Antecedentes
- El oncogén MYC se sobreexpresa con frecuencia en los cánceres, impulsando el crecimiento tumoral.
- Los cuádruplexos G, como el del promotor MYC (MycG4), son objetivos potenciales de fármacos específicos para el cáncer.
- Las indenoisoquinolinas muestran una potente actividad anticancerígena, pero su mecanismo más allá de la inhibición de la topoisomerasa I no está claro.
Objetivo Del Estudio
- Investigar el mecanismo de acción de las indenoisoquinolinas contra el cáncer.
- Para determinar si las indenoisoquinolinas se dirigen al cuádruple MycG4.
- Explorar el potencial de la doble inhibición de MYC y topoisomerasa I para el tratamiento del cáncer.
Principales Métodos
- Ensayos bioquímicos y biofísicos para el estudio de las interacciones indenoisoquinolina-MycG4.
- Modelado por computadora para entender el enlace.
- Ensayos basados en células para evaluar la expresión de MYC y los efectos anticancerígenos.
- Análisis de la relación estructura-actividad.
Principales Resultados
- Las indenoisoquinolinas anticancerígenas se unen y estabilizan fuertemente el cuádruple MycG4.
- Estos compuestos reducen significativamente la expresión de MYC en las células cancerosas.
- Se observó un efecto sinérgico entre la inhibición de MYC y la inhibición de la topoisomerasa I en la actividad anticancerígena.
Conclusiones
- Las indenoisoquinolinas representan una nueva clase de fármacos dirigidos al promotor de MYC G-quadruplex para la supresión de MYC.
- La doble orientación de MYC y topoisomerasa I presenta una nueva estrategia terapéutica para el desarrollo de fármacos contra el cáncer.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
The difference between the calculated and experimentally measured masses is known as the mass defect of the atom. In the case of helium-4, the mass defect indicates a “loss” in mass of 4.0331 amu – 4.0026 amu = 0.0305 amu. The loss in mass accompanying the formation of an atom from protons, neutrons, and electrons is due to the conversion of that mass into energy that is evolved as the atom forms. The nuclear binding energy is the energy produced when the atoms’ nucleons are bound...